HUTCHMED (China) Ltd (HCM) stock

HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30

$14.90+0.05 (+0.34%)

Close on Nov 13, 2026Market cap $2.60BP/E 5.7Yield –

HUTCHMED (China) gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 38.7%, against 44.6% the year before. The highest annual figure on record is 54.1% in fiscal 2023.

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	38.7%	−6.0
FY2024	Dec 31, 2024	44.6%	−9.5
FY2023	Dec 31, 2023	54.1%	+27.1
FY2022	Dec 31, 2022	27.0%	−2.6
FY2017	Dec 31, 2017	29.6%	−1.4
FY2016	Dec 31, 2016	31.0%	−10.2
FY2015	Dec 31, 2015	41.2%	+2.4
FY2014	Dec 31, 2014	38.8%	–

Parsed from the XBRL in HUTCHMED (China)'s annual and quarterly filings with the SEC
Per-share figures adjusted for the 10-for-1 split on May 30, 2019
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing